Stay updated on Aducanumab for Early Alzheimer's: Clinical Trial
Sign up to get notified when there's something new on the Aducanumab for Early Alzheimer's: Clinical Trial page.

Latest updates to the Aducanumab for Early Alzheimer's: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedExpanded and reorganized the Locations section to include an expanded set of study sites across the United States, Canada, and multiple European regions, with new locations added and some existing ones removed.SummaryDifference2%

- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedAdded an auto-fill provenance note indicating publications are automatically pulled from PubMed and may not relate to the study. Updated the page revision indicator to v3.3.2 and removed the older PubMed-origin wording from v3.2.0.SummaryDifference0.0%

- Check40 days agoChange DetectedRemoved the government funding and operating status notice from the page.SummaryDifference0.1%

- Check62 days agoChange DetectedNo significant additions or deletions were found in the Study Details page; the content appears unchanged between versions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check83 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference2%

- Check90 days agoChange DetectedUpdated page now shows Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) while retaining an earlier Revision: v3.0.2. This indicates a restructuring/revision of content with emphasis on versioning rather than new core information.SummaryDifference0.3%

Stay in the know with updates to Aducanumab for Early Alzheimer's: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Aducanumab for Early Alzheimer's: Clinical Trial page.